Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07144904 · ClinicalTrials.gov registry record · Phase 4
Assessing the Efficacy of Indocyanine Green for Ureter Identification During Robot-Assisted Surgery in Advanced-Stage Endometriosis
A Phase 4 study, sponsored by Baylor College of Medicine.
- Not yet
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT07144904 is a Phase 4 study that has not yet begun recruiting, run by Baylor College of Medicine. The registered enrollment target is 40 participants.
The verdict
NCT07144904, a Phase 4 study, has not yet begun recruiting, sponsored by Baylor College of Medicine.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of this side-randomized, self-controlled trial, 1-site study is to explore the efficacy of Indocyanine Green Fluorescence (ICG) for Intraoperative Ureter Identification During Robot-Assisted Single-Site Surgery in Advanced-Stage Endometriosis. Researchers will perform temporary ureteral stent using indocyanine green fluorescence for intraoperative ureteral identification on either the left or right side of subjects who are undergoing a robotic assisted transumbilical resection of advanced endometriosis. Participants will be randomized to receive ICG-assisted ureteral identification on either the left or right side. Randomization will be conducted using a computer-generated block randomization method. The primary aim is to determine whether ICG-assisted ureter visualization can reduce operative time for endometriosis resection and ureterolysis, and minimize the risk of ureteral injury. Secondary objectives are to assess the feasibility and safety of temporary ureteral ICG stenting for intraoperative ureter identification in advanced endometriosis.
Interventions
- DRUG Indocyanine Green (ICG)-Assisted Ureteral Identification
- PROCEDURE Standard Ureteral Identification without ICG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2026-03-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07144904
The ClinicalTrials.gov registry entry for NCT07144904 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Indocyanine Green (ICG)-Assisted Ureteral Identification is the first listed.
NCT07144904 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07144904 about?
NCT07144904 is a clinical study titled "Assessing the Efficacy of Indocyanine Green for Ureter Identification During Robot-Assisted Surgery in Advanced-Stage Endometriosis". The goal of this side-randomized, self-controlled trial, 1-site study is to explore the efficacy of Indocyanine Green Fluorescence (ICG) for Intraoperative Ureter Identification During Robot-Assisted Single-Site Surgery in Advanced-Stage Endometriosis. Researchers will perform temporary ureteral st...
What is the current status of trial NCT07144904?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2025-10-01. Estimated completion is 2026-03-15.
What interventions are being tested in trial NCT07144904?
The interventions under investigation include: Indocyanine Green (ICG)-Assisted Ureteral Identification (DRUG), Standard Ureteral Identification without ICG (PROCEDURE).
Who is sponsoring clinical trial NCT07144904?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.